The impact of parallel regulatory-HTA scientific advice on clinical development. Assessing the uptake of regulatory and HTA recommendations.
| Author | |
|---|---|
| Abstract |
:
The "Parallel regulatory-HTA SA" (PSA) procedure allows manufacturers to receive simultaneous feedback from both EU regulators and HTA bodies on development plans for new medicines. |
| Year of Publication |
:
2018
|
| Journal |
:
British journal of clinical pharmacology
|
| Date Published |
:
2018
|
| ISSN Number |
:
0306-5251
|
| URL |
:
http://dx.doi.org/10.1111/bcp.13524
|
| DOI |
:
10.1111/bcp.13524
|
| Short Title |
:
Br J Clin Pharmacol
|
| Download citation |
